|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on July 8, 2003
Accepted on December 17, 2003
Molecular Diagnostics and Genetics |
1 Division of Genetics, Departments of Pediatrics, Obstetrics and Gynecology, Tufts-New England Medical Center, Boston, MA
2 DM-STAT, Inc., Medford, MA
3 Genzyme, Framingham, MA
4 Departments of Obstetrics and Gynecology, and Molecular and Human Genetics, Baylor College Medicine, Houston, TX
5 Department of Obstetrics and Gynecology, University Women’s Hospital, University of Basel, Basel, Switzerland
6 Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL
* To whom correspondence should be addressed. E-mail: kjohnson{at}tufts-nemc.org.
Background: Analysis of fetal DNA from maternal plasma by PCR offers great potential for noninvasive prenatal genetic diagnosis. To further evaluate this potential, we developed and validated a standard protocol to determine whether fetal DNA sequences could be reproducibly amplified and measured across multiple laboratories in a common set of specimens.
Methods: Each of five participating centers in a National Institute of Child Health and Human Development consortium collected 20 mL of peripheral blood from 20 pregnant women between 10 and 20 weeks of gestation. The plasma fraction was separated according to a common protocol, divided, and frozen in five aliquots. One aliquot was shipped to each participating laboratory, where DNA was extracted according to a standard protocol. All plasma samples (n = 100) were then analyzed blindly for the presence and quantity of total DNA (GAPDH) and male fetal DNA (SRY) by real-time PCR. Genomic DNA was isolated from female and male cells at one center, quantified, and shipped to the others to serve as calibrators for GAPDH and SRY, respectively.
Results: The amplification of known quantities of DNA was consistent among all centers. The mean quantity of male DNA amplified from maternal plasma when the fetus was male ranged from 51 to 228 genome equivalents (GE)/mL. Qualitative concordance was found overall among centers. The sensitivity of the assay for detection of male DNA when the fetus was male varied from 31% to 97% among centers. Specificity was more consistent (92.8-100%) with only four false-positive results obtained across the entire study.
Conclusions: All centers were able to consistently amplify frozen and shipped DNA. The PCR procedure used here is reliable and reproducible. Centers that extracted and amplified more DNA per milliliter of maternal plasma had superior sensitivities of Y chromosome sequence detection. The specificity of the assay was more consistent among centers. A robust and thoroughly optimized protocol for the extraction of DNA from maternal plasma is needed to make testing of fetal DNA in maternal plasma a clinically relevant analytical tool.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Chevillotte, A. Schubert, T. Mertens, and J. von Einem Fluorescence-Based Assay for Phenotypic Characterization of Human Cytomegalovirus Polymerase Mutations Regarding Drug Susceptibility and Viral Replicative Fitness Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3752 - 3761. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Shekhtman, K. Anne, H. S. Melkonyan, D. J. Robbins, S. L. Warsof, and S. R. Umansky Optimization of Transrenal DNA Analysis: Detection of Fetal DNA in Maternal Urine Clin. Chem., April 1, 2009; 55(4): 723 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Jorgez, D. D. Dang, R. Wapner, A. Farina, J. L. Simpson, and F. Z. Bischoff Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21 Hum. Reprod., August 1, 2007; 22(8): 2267 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lapaire, D. W. Bianchi, I. Peter, B. O'Brien, H. Stroh, J. M. Cowan, U. Tantravahi, and K. L. Johnson Cell-Free Fetal DNA in Amniotic Fluid: Unique Fragmentation Signatures in Euploid and Aneuploid Fetuses Clin. Chem., March 1, 2007; 53(3): 405 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stanghellini, R. Bertorelli, L. Capone, V. Mazza, C. Neri, A. Percesepe, and A. Forabosco Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe Mol. Hum. Reprod., September 1, 2006; 12(9): 587 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lapaire, H. Stroh, I. Peter, J. M. Cowan, U. Tantravahi, B. O'Brien, D. W. Bianchi, and K. L. Johnson Larger Columns and Change of Lysis Buffer Increase the Yield of Cell-Free DNA Extracted from Amniotic Fluid Clin. Chem., January 1, 2006; 52(1): 156 - 157. [Full Text] [PDF] |
||||
![]() |
P. D. Pan, I. Peter, G. M. Lambert-Messerlian, J. A. Canick, D. W. Bianchi, and K. L. Johnson Cell-free fetal DNA levels in pregnancies conceived by IVF Hum. Reprod., November 1, 2005; 20(11): 3152 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zimmermann, A. El-Sheikhah, K. Nicolaides, W. Holzgreve, and S. Hahn Optimized Real-Time Quantitative PCR Measurement of Male Fetal DNA in Maternal Plasma Clin. Chem., September 1, 2005; 51(9): 1598 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.M. D. Lo Recent Advances in Fetal Nucleic Acids in Maternal Plasma J. Histochem. Cytochem., March 1, 2005; 53(3): 293 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gonzalez-Gonzalez, M. Garcia-Hoyos, M. J. Trujillo-Tiebas, I. Lorda-Sanchez, M. R. de Alba, F. Infantes, J. Gallego, J. Diaz-Recasens, C. Ayuso, and C. Ramos Application of Fetal DNA Detection in Maternal Plasma: A Prenatal Diagnosis Unit Experience J. Histochem. Cytochem., March 1, 2005; 53(3): 307 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. R. Chinnapapagari, W. Holzgreve, O. Lapaire, B. Zimmermann, and S. Hahn Treatment of Maternal Blood Samples with Formaldehyde Does Not Alter the Proportion of Circulatory Fetal Nucleic Acids (DNA and mRNA) in Maternal Plasma Clin. Chem., March 1, 2005; 51(3): 652 - 655. [Full Text] [PDF] |
||||
![]() |
F. Z. Bischoff, D. E. Lewis, and J. L. Simpson Cell-free fetal DNA in maternal blood: kinetics, source and structure Hum. Reprod. Update, January 1, 2005; 11(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |